We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Osenvelt, Stoboclo
Australian Public Assessment Report
Device/Product Name
Osenvelt, Stoboclo
Active ingredients
Denosumab
AusPAR Date
Published
Submission Number
PM-2024-00632-1-5
Submission Type
New biosimilar entity
Decision
Approved